Shandong Buchang Pharmaceuticals Co Ltd (603858) — Cash Flow Quality Index
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Cash Flow Quality Index of -0.60x as of September 2025. Operating cash flow of CN¥-145.26 Million is below net income of CN¥240.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 603858 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Shandong Buchang Pharmaceuticals Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603858 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shandong Buchang Pharmaceuticals Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Shandong Buchang Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see market cap of Shandong Buchang Pharmaceuticals Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.08x | CN¥-164.26 Million | CN¥151.87 Million | ▼ -201.2% |
| 2021 | 1.07x | CN¥1.32 Billion | CN¥1.24 Billion | ▲ +0.6% |
| 2020 | 1.06x | CN¥1.96 Billion | CN¥1.84 Billion | ▼ -20.4% |
| 2019 | 1.34x | CN¥2.62 Billion | CN¥1.96 Billion | ▲ +24.2% |
| 2018 | 1.08x | CN¥2.05 Billion | CN¥1.91 Billion | ▼ -10.2% |
| 2017 | 1.20x | CN¥1.96 Billion | CN¥1.64 Billion | ▲ +27.0% |
| 2016 | 0.94x | CN¥1.67 Billion | CN¥1.77 Billion | ▲ +57.1% |
| 2015 | 0.60x | CN¥2.12 Billion | CN¥3.53 Billion | ▼ -49.1% |
| 2014 | 1.18x | CN¥1.78 Billion | CN¥1.51 Billion | ▲ +42.8% |
| 2013 | 0.83x | CN¥1.11 Billion | CN¥1.35 Billion | ▼ -23.3% |
| 2012 | 1.08x | CN¥1.35 Billion | CN¥1.25 Billion | — |